Landry Robert E Insider Trades

Insider Trading History

Track insider trading activity for Landry Robert E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $834k 10,184 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$552k 7,152 shares
$77.15
$81.93
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $284k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$24.66
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $1.53M 62,000 shares
Last Trade
Aug 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$771k 62,000 shares
$12.44
$24.66
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $891k 10,880 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$326k 10,880 shares
$30.00
$81.93
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $2.09M 25,538 shares
Last Trade
Feb 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 25,538 shares
$42.21
$81.93
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.5M 23,693 shares
Last Trade
Feb 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$269k 281 shares
$956.65
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $7.73M 11,787 shares
Last Trade
Feb 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 400 shares
$945.18
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.7M 23,974 shares
Last Trade
Feb 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 400 shares
$945.18
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.5M 23,574 shares
Last Trade
Jan 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$269k 282 shares
$953.42
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.7M 23,856 shares
Last Trade
Jan 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 400 shares
$942.78
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $8M 12,187 shares
Last Trade
Jan 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 400 shares
$942.78
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.4M 23,456 shares
Last Trade
Jan 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$335k 352 shares
$951.26
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $8.26M 12,587 shares
Last Trade
Jan 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$474k 500 shares
$948.24
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.6M 23,808 shares
Last Trade
Jan 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$474k 500 shares
$948.24
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $8.59M 13,087 shares
Last Trade
Jan 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 1,100 shares
$954.58
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.3M 23,308 shares
Last Trade
Jan 23, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$736k 776 shares
$948.50
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.8M 24,084 shares
Last Trade
Jan 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 1,100 shares
$954.58
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $9.31M 14,187 shares
Last Trade
Jan 17, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$465k 500 shares
$929.13
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.3M 23,338 shares
Last Trade
Jan 17, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$465k 500 shares
$929.13
$656.12
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $15.1M 22,984 shares
Last Trade
Jan 17, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$330k 354 shares
$932.34
$656.12

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up